81 related articles for article (PubMed ID: 28190648)
1. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol.
Creasman WT; Ali S; Mutch DG; Zaino RJ; Powell MA; Mannel RS; Backes FJ; DiSilvestro PA; Argenta PA; Pearl ML; Lele SB; Guntupalli SR; Waggoner S; Spirtos N; Boggess JF; Edwards RP; Filiaci VL; Miller DS
Gynecol Oncol; 2017 Jun; 145(3):519-525. PubMed ID: 28392124
[TBL] [Abstract][Full Text] [Related]
2. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ
Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259
[TBL] [Abstract][Full Text] [Related]
3. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract][Full Text] [Related]
4. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer.
Matsuo K; Machida H; Stone RL; Soliman PT; Thaker PH; Roman LD; Wright JD
Obstet Gynecol; 2017 Aug; 130(2):403-410. PubMed ID: 28697110
[TBL] [Abstract][Full Text] [Related]
5. Is it safe to operate selected low-risk endometrial cancer patients in secondary hospitals?
Narva S; Polo-Kantola P; Oksa S; Kallio J; Huvila J; Rissanen T; Hynninen J; Hietanen S; Joutsiniemi T
Eur J Surg Oncol; 2024 Jun; 50(6):108317. PubMed ID: 38581756
[TBL] [Abstract][Full Text] [Related]
6. Pathological and molecular diagnosis of bilateral inguinal lymph nodes metastases from low-grade endometrial adenocarcinoma: a case report with review of the literature.
Perrone AM; Girolimetti G; Cima S; Kurelac I; Livi A; Caprara G; Santini D; Castellucci P; Morganti AG; Gasparre G; De Iaco P
BMC Cancer; 2018 Jan; 18(1):7. PubMed ID: 29295713
[TBL] [Abstract][Full Text] [Related]
7. The Futility of Systematic Lymphadenectomy in Early-Stage Low-grade Endometrial Cancer.
Nayyar N; Lakhwani P; Goel A; Pande PK; Kumar K
Indian J Surg Oncol; 2018 Jun; 9(2):204-210. PubMed ID: 29887702
[TBL] [Abstract][Full Text] [Related]
8. Minimally invasive approach is preferred for clinical stage 1 endometrioid-type endometrial cancer.
Wang PH; Yang ST
J Chin Med Assoc; 2024 Apr; 87(4):347-349. PubMed ID: 38349141
[No Abstract] [Full Text] [Related]
9. Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery based on dispersion of recurrence probability.
Yamashita T; Itoh T; Asano T; Suina A; Nishimori M; Munakata S; Satoh H
Int J Clin Oncol; 2024 Feb; 29(2):222-231. PubMed ID: 38177623
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Lymph Node Mapping in Endometrial Cancer: A Comprehensive Review.
Zhai L; Zhang X; Cui M; Wang J
Front Oncol; 2021; 11():701758. PubMed ID: 34268126
[TBL] [Abstract][Full Text] [Related]
11. Pre-surgical staging in endometrial cancer: An opportunity for risk stratification and triage?
Jose T; Singh A; Vardhan S
Med J Armed Forces India; 2021 Apr; 77(2):205-213. PubMed ID: 33867639
[TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical outcomes and postoperative quality of life after surgical treatment of type II submucous myoma via laparoscopy or hysteroscopy.
Zhang RC; Wu W; Zou Q; Zhao H
J Int Med Res; 2019 Sep; 47(9):4126-4133. PubMed ID: 31280641
[TBL] [Abstract][Full Text] [Related]
13. Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma.
Park JY; Hong DG; Chong GO; Park JY
Pathol Oncol Res; 2019 Apr; 25(2):723-730. PubMed ID: 30604272
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-α targeted near-infrared fluorescence imaging in high-risk endometrial cancer patients: a tissue microarray and clinical feasibility study.
Boogerd LSF; Hoogstins CES; Gaarenstroom KN; de Kroon CD; Beltman JJ; Bosse T; Stelloo E; Vuyk J; Low PS; Burggraaf J; Vahrmeijer AL
Oncotarget; 2018 Jan; 9(1):791-801. PubMed ID: 29416655
[TBL] [Abstract][Full Text] [Related]
15. Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.
Korkmaz V; Meydanli MM; Yalçın I; Sarı ME; Sahin H; Kocaman E; Haberal A; Dursun P; Güngör T; Ayhan A
J Gynecol Oncol; 2017 Nov; 28(6):e78. PubMed ID: 29027396
[TBL] [Abstract][Full Text] [Related]
16. Sentinel Lymph Node Biopsy in Endometrial Cancer: a New Standard of Care?
Sullivan SA; Rossi EC
Curr Treat Options Oncol; 2017 Sep; 18(10):62. PubMed ID: 28921419
[TBL] [Abstract][Full Text] [Related]
17. Prospective validation of an intraoperative algorithm to guide surgical staging in early endometrial cancer.
Lefringhouse JR; Elder JW; Baldwin LA; Miller RW; DeSimone CP; van Nagell JR; Samoyoa LM; West DS; Dressler EV; Liu M; Ueland FR
Gynecol Oncol; 2017 Apr; 145(1):50-54. PubMed ID: 28190648
[TBL] [Abstract][Full Text] [Related]
18. Sentinel lymph node biopsy in endometrial cancer-Feasibility, safety and lymphatic complications.
Geppert B; Lönnerfors C; Bollino M; Persson J
Gynecol Oncol; 2018 Mar; 148(3):491-498. PubMed ID: 29273307
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
